Company Description
DURECT wants your medicine to go DURECTly where it's needed. It is developing drug-delivery systems to provide long-term therapy for such conditions...
Key DURECT Financials
| Company Type | Public - NASDAQ (GM): DRRX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $30.7 |
| 2005 Employees | 138 |
More DURECT Financials (11 pages)
Latest DURECT Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about DURECT's competition across multiple industries
Top DURECT Competitors
Sponsored Links
The Business Directory
DURECT Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, Chief Scientific Officer, and Director | Felix Theeuwes | Network | E-mail |
| President, CEO, and Director | James E. Brown | Network | E-mail |
| CFO | Matthew J. Hogan | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current DURECT News
- USE OF GLUCOCORTICOIDS FOR TREATMENT OF CONGESTIVE HEART FAILURE [PCT Biblio Info] (29 Sep 2008 11:58:00 EDT)
- BioWorld Today September 23, 2008 [BioWorld Today] (23 Sep 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (22 Sep 2008 23:00:00 EDT)
Sponsored Opportunity
